---
title: "alfacalcidol - Renal osteodystrophy"
sidebar: mydoc_sidebar
permalink: alfacalcidolrenalosteodystrophy.html
toc: false 
---

{% include image.html url="images/alfacalcidolrenalosteodystrophy.png" file="alfacalcidolrenalosteodystrophy.png" alt="alfacalcidolrenalosteodystrophy" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C008088 | alfacalcidol | Drug |
| UniProt:O15528 | 25-hydroxylase | Protein |
| MESH:D002117 | calcitriol | ChemicalSubstance |
| UniProt:P11473 | vitamin D receptor | Protein |
| UniProt:P19793 | retinoid-X receptor | Protein |
| GO:0045453 | osteoclastic resorption | BiologicalProcess |
| MESH:D002118 | calcium | ChemicalSubstance |
| MESH:D012080 | Renal osteodystrophy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Alfacalcidol | INTERACTS WITH | 25-Hydroxylase |
| 25-Hydroxylase | INCREASES ABUNDANCE OF | Calcitriol |
| Calcitriol | INCREASES ACTIVITY OF | Vitamin D Receptor |
| Vitamin D Receptor | IN COMPLEX WITH | Retinoid-X Receptor |
| Retinoid-X Receptor | POSITIVELY REGULATES | Osteoclastic Resorption |
| Osteoclastic Resorption | INCREASES SECRETION OF | Calcium |
| Calcium | TREATS | Renal Osteodystrophy |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01436#mechanism-of-action](https://go.drugbank.com/drugs/DB01436#mechanism-of-action){:target="_blank"}